AudioMedica News Integrase Inhibitor Raltegravir Doubles Antiviral Response Rate in Treatment Experienced HIV-Infected Patients Compared to Optimised...
AudioMedica News Three-Class Antiretroviral Therapy for HIV Not Appropriate: Results from the FIRST Study Play Episode Pause Episode Mute/Unmute...